Molecular analysis of signaling events mediated by the cytoplasmic domain of leukemia inhibitory factor receptor α subunit

Molecular and Cellular Biochemistry

Volumn 258, Issue 1-2, 2004, Pages 15-23

  Liu, Houqui ^a   Liu, Shanrong ^a   Tang, Shuping ^a   Ji, Kaihong ^a   Wang, Fengmei ^a   Shan, Jikuang ^a   Hu, Shijie ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CD15; Chimera; Differentation; gp130; gp190; LIF

Indexed keywords

BIOLOGICAL MARKER; CD15 ANTIGEN; GLYCOPROTEIN GP 130; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR; PROTEIN TYROSINE PHOSPHATASE; STAT3 PROTEIN; TYROSINE;

ALPHA CHAIN; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN HL 60; CELLULAR DISTRIBUTION; CHIMERA; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKEMIA CELL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WILD TYPE;

ANTIGENS, CD; ANTIGENS, CD15; ARTIFICIAL GENE FUSION; CDC25 PHOSPHATASE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CYTOKINE RECEPTOR GP130; CYTOPLASM; DIMERIZATION; DNA-BINDING PROTEINS; HL-60 CELLS; HUMANS; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA SUBUNIT; MEMBRANE GLYCOPROTEINS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CYTOKINE; RECEPTORS, OSM-LIF; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSFECTION;

EID: 1442306611     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000012829.10405.e1     Document Type: Article

References (47)

1. Hilton DJ: LIF: Lots of interesting functions. Trends Biochem Sci 17: 73-76, 1992
2. Gearing DP, Comeau NR, Friend DJ, Gimpel SD, Thut CJ, McGourty J, Brasher KK, King JA, Gillis S, Mosley B: The IL-6 signal transducer, gp130: An oncostatin M receptor and affinity converter for the LIF receptor. Science 255: 1434-1437, 1992
3. Ip NY, Nye SH, Boulton TG, Davis S, Taga T, Li Y, Birren SJ, Yasukawa K, Kishimoto T, Anderson DJ: CNTF and LIF act on neuronal cell via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 69: 1121-1132, 1992
4. Gearing DP, Thut CJ, Vande BT, Gimpel SD, Delaney PB, King J, Price V, Cosman D, Beckmann MP: Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp 130. EMBO J 10: 2839-2848, 1991
5. Rao MS, Symes A, Malik N, Shoyab M, Fink JS, Landis SC: Oncostatin M regulates VIP expression in a human neuroblastoma cell line. Neuroreport 3: 865-868, 1992
6. Taga T, Narazaki M, Yasukawa K, Saito T, Miki D, Hamaguchi M, Davis S, Shoyab M, Yancopoulos GD, Kishimoto T: Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the IL-6 signal transducer gp 130. Proc Natl Acad Sci USA 89: 10998-11001, 1992
7. Zhong Z, Wen Z, Darnell JE: Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264: 95-98, 1994
8. Lai C-F, Ripperger J, Morella KK, Wang Y, Gearing DP, Fey GH, Baumann H: Separate signaling mechanisms are involved in the control of STAT protein activation and gene regulation via the interleukin 6 response element by the box 3 motif of gp 130. J Biol Chem 270: 14847-14850, 1995
9. Baumann H, Ziegler SF, Mosley B, Morella KK, Pajovic S, Gearing DP: Reconstitution of the response to leukemia inhibitory factor, oncostatin M and ciliary neurotrophic factor in hepatoma cells. J Biol Chem 268: 8414-8417, 1993
10. Yamanaka Y, Nakajima K, Fukada T, Hibi M, Hirano T: Differentiation and growth arrest signals are generated through the cytoplasmic region of gp 130 that is essential for Stat3 activation. EMBO 115: 1557-1565, 1996
11. Murakami M, Narazaki M, Hibi M, Yawata H, Yasukawa K, Hamaguchi M, Taga T, Kishimoto T: Critical cytoplasmic region of the interleukin-6 signal transducer gp 130 is conserved in the cytokine receptor family. Proc Natl Acad Sci USA, 88: 11349-11353, 1991
12. Stahl N, Boulton TG, Farruggella T, Ip NY, Davis S, Witthuhn BA, Quelle FW, Silvennoinen O, Barbieri G, Pellegrini S: Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta-receptor components. Science 263: 92-95, 1994
13. Argetsinger LS, Campbell GS, Yang X, Witthuhn BA, Silvennoinen O, Ihle JN, Carter-Su C: Identification of JA-K2 as a growth hormone receptor-associated tyrosine kinase. Cell 74: 237-244, 1993
14. Baumann H, Symes AJ, Comeau NM, Morella KK, Wang Y, Friend D, Ziegler SF, Fink JS, Gearing DP: Multiple regions within the cytoplasmic domains of the leukemia inhibitory factor and gp130 cooperate in signal transduction in hepatic and neuronal cells. Mol Cell Biol 14: 138-146, 1994
15. Schiemann WP, Bartoe JL, Nathanson NM: Box3-independent signal mechanisms are involved in leukemia inhibitory factor receptor α and gp130-mediated stimulation of mitogen-activated kinase. J Biol Chem 272: 16631-16636, 1997
16. Stahl N, Fan-uggella TJ, Boulton TG, Zhong Z, Darnell JE Jr, Yancopoulos GD: Choice of STATS and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267: 1349-1353, 1995
17. Schiemann WP, Graves LM, Baumann H, Morella KK, Gearing DP, Nielsen MD, Krebs EG, Nathanson NM: Phosphorylation of the human leukemia inhibitory factor (LIF) receptor by mitogen-activated protein kinase and the regulation of LIF receptor function by heterologous receptor activation. Proc Natl Acad Sci USA 92: 5361-5365, 1995
18. Starr R, Novak U, Willson TA, Inglese M, Murphy V, Alexander WS, Metcalf D, Nicola NA, Hilton DJ, Ernst M: Distinct roles for leukemia inhibitory factor α chain and gp130 in cell type-specific signal transduction. J Biol Chem 272: 19982-19986, 1997
19. Minami M, Inoue M, Wei S, Takeda K, Matsumoto M, Kishimoto T, Akira S: STAT3 activation is a critical step in gp 130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc Natl Acad Sci USA 93: 3963-3966, 1996
20. Kiuchi N, Nakajima K, Ichiba M, Fukada T, Narimatsu M, Mizuno K, Hibi M, Hirano T: STAT3 is required for the gp 130-mediated full activation of the c-myc gene. J Exp Med 189: 63-73, 1999
21. Tomida MI, Heike T, Yokota T: Cytoplasmic domains of the leukemia inhibitory factor receptor required for STAT3 activation, differentiation, and growth arrest of myeloid leukemic cells. Blood 93: 1934-1941, 1999
22. Galaktionov K, Beach D: Specific activation of Cdc25 tyrosine phosphatases by B-type cyclins: Evidence for multiple roles of mitotic cyclins. Cell 67: 1181-1194, 1991
23. Nilsson I, Hoffmann I: Cell cycle regulation by the Cdc25 phosphatase family. Prog Cell Cycle Res 4: 107-114, 2000
24. Liu HQ, Shan JK, Tang SP: Involving of the cytoplasmic domain of leukemia inhibitory factor (LIF) receptor a subunit, IL-6 related signal transducer-gp 130 or Fas death domain for MAPK p42/44 activation in HL-60 cell with LIF or anti-Fas IgG. Mol Cell Biochem 217: 113-120, 2001
25. Zhu K, Liu HQ, Liu XP, Fu JL: Cloning and expression of leukemia inhibitory factor in CHO cell line and its inhibitory effect on the proliferation of U937. J Exp Hematology 6: 190-193, 1998
26. Maekawa T, Metcalf D: Colonial suppression of HL-60 and U937 cells by recombinant leukemia inhibitory factor in combination with GM-CSF or G-CSF. Leukemia 3: 270-276, 1989
27. Gough NM, Williams RL: The pleiotropic actions of leukemia inhibitory factor. Cancer Cell 1: 77-80, 1989
28. Nakajima K, Yamanaka Y, Nakae K, Kojima H, Ichiba M, Kiuchi N, Kitaoka T, Fukada T, Hibi M, Hirano T: A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J 15: 3651-3658, 1996
29. Senga T, Iwamoto T, Kitamura T, Miyake Y, Hamaguchi M: JAK/STAT3-dependent activation of the RalGDS/Ral pathway in M1 mouse myeloid leukemia cells. J Biol Chem 276: 32678-32681, 2001
30. Tomida M: Structural and functional studies on the leukemia inhibitory factor receptor (lif-r): Gene and soluble form of lif-r, and cytoplasmic domain of lif-r required for differentiation and growth arrest of myeloid leukemic cells. Leuk Lymphoma 37:517-525, 2000
31. Hermanns HM, Radtke S, Haan C, Schmitz-Van de Leur H, Tavernier J, Heinrich PC, Behrmann I: Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130. J Immunol 163: 6651-6658, 1999
32. Zhang JG; Zhang Y, Owczarek CM, Ward LD, Moritz RL, Simpson RJ, Yasukawa K, Nicola NA: Identification and characterization of two distinct truncated forms of gp130 and a soluble form of leukemia inhibitory factor receptor alpha-chain in normal human urine and plasma. J Biol Chem 273: 10798-10805, 1998
33. Layton MJ, Cross BA, Metcalf D, Ward LD, Simpson RJ, Nicola NA: A major binding protein for leukemia inhibitory factor in normal mouse serum: Identification as a soluble form of the cellular receptor. Proc Natl Acad Sci USA 89: 8616-8620, 1992
34. Yamaguchi-Yamamoto Y, Tomida M, Hozumi M: Pregnancy associated increase in differentiation-stimulating factor (D-factor)/leukemia inhibitory factor (LIF)-binding substance(s) in mouse serum. Leuk Res 17: 515-522, 1993
35. Schaeffer M, Schneiderbauer M, Weidler S, Tavares R, Warmuth M, de Vos G, Hallek M: Signaling through a novel domain of gp130 mediates cell proliferation and activation of Hck and Erk kinases. Mol Cell Biol 21: 8068-8081, 2001
36. Kimura T, Sakabe H, Minamiguchi H, Fujiki H, Abe T, Kaneko H, Yokota S, Nakagawa H, Fujii H, Tamaki H, Ogawa H, Sugiyama H, Sonoda Y: Interleukin-11 (IL-11) enhances clonal proliferation of acute myelogenous leukemia cells with strong expression of the IL-11 receptor alpha chain and signal transducing gp 130. Leukemia 13: 1018-1027, 1999
37. Shirogane T, Fukada T, Muller JM, Shima DT, Hibi M, Hirano T: Synergistic roles for Pim-I and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis. Immunity 111: 709-719, 1999
38. Smithgall TE, Briggs SD, Schreiner S, Lerner EC, Cheng H, Wilson MB: Control of myeloid differentiation and survival by Stats. Oncogene 19: 2612-2618, 2000
39. Hirano T, Ishihara K, Hibi M: Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19: 2548-2556, 2000
40. Goldstone S, Pavey S, Forrest A, Sinnamon J, Gabrielli B: Cdc25-dependent activation of cyclin A/cdk2 is blocked in G2 phase arrested cells independently of ATM/ATR. Oncogene 20: 921-932, 2001
41. Lammer C, Wagerer S, Saffrich R, Mertens D, Ansorge W, Hoffmann I: The cdc25B phosphatase is essential for the G2/M phase transition in human cells. J Cell Sci 111: 2445-2453, 1998
42. Blanchard F, Duplomb L, Wang Y, Robledo O, Kinzie E, Pitard V, Godard A, Jacques Y, Baumann H: Stimulation of leukemia inhibitory factor receptor degradation by extracellular signal-regulated kinase. J Biol Chem 275: 28793-28801, 2000
43. Anhuf D, Weissenbach M, Schmitz J, Sobota R, Hermanns HM, Radtke S, Linnemann S, Behrmann I, Heinrich PC, Schaper F: Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: Structural receptor requirements for signal attenuation. J Immunol 165: 2535-43, 2000
44. Hanjan SN, Kearney JF, Cooper MD: A monoclonal antibody (MMA) that identifies a differentiation antigen on human myelomonocytic cells. Clin Immunol Immunopathol 23: 172-188, 1982
45. Civin CL, Mirro J, Banquerigo ML: My-1, new myeloid-specific antigens identified by a mouse monoclonal antibody. Blood 57: 842-845, 1981
46. Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL, Gregory CD: Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 392: 505-509, 1998
47. Mills KI, Woodgate LJ, Gilkes AF, Walsh V, Sweeney MC, Brown G, Burnett AK: Inhibition of mitochondrial function in HL-60 cells is associated with an increased apoptosis and expression of CD14. Biochem Biophys Res Commun 263: 294-300, 1999